Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

Healthsense Closes $10 Million Financing with Boston-Based Mansa Capital

Boston, Mass. & Minneapolis, Minn. – Aug. 19, 2014 – Healthsense,® Inc., the fastest growing provider of technology-enabled care solutions for the senior care continuum, announced today that it has closed on $10 million in financing led by Mansa Capital, a Boston-based  private equity firm focused on the $2.8 trillion U.S. healthcare market. Previous investors Merck Global Health Innovation Fund and Radius Ventures LLC also participated in the round.
 
“Mansa Capital possesses exceptionally strong relationships that Healthsense can leverage to expand our reach into the managed care and home health markets, where we see major growth opportunities. This is an ideal complement to our thriving senior living business,” said Healthsense President and CEO A.R. Weiler“Mansa Capital’s involvement will extend the exceptional benefits we have realized from previous investments with Merck GHI, Radius and B.C. Ziegler and Company, influential investors whose market knowledge and resources have helped us achieve our continued growth and success.”
 
With Healthsense’s growing focus on helping managed care organizations optimize care, the firm has deployed several pilot programs within the last year including partnerships with Humana Cares/Senior Bridge, Fallon Health, and various others. Early program results suggest a positive impact of the Healthsense eNeighbor® remote monitoring platform on improving care outcomes for those with chronic health conditions by providing earlier interventions and readmission rate reductions in various care environments.  

“We seek to engage with companies that demonstrate both strong growth potential and the ability to advance the healthcare industry’s Triple Aim of improving care, reducing costs and enhancing the patient experience,” said Mansa Capital Managing Partner and Chief Investment Officer Ruben King-Shaw Jr., who will join the Healthsense Board of Directors. “Healthsense embodies all that we look for when considering an addition to our healthcare portfolio, particularly given the ever-increasing industry focus on managed care.”

Headquartered in Boston, Mansa Capital invests primarily in high-growth healthcare services and technology companies with experienced management teams, sound business franchises and substantial potential. The healthcare private equity investment firm seeks to develop companies that deliver advances in cost-effective care, demonstrate potential for strong organic revenue growth, and exhibit attractive margins as well as high returns on capital.
 



About Healthsense, Inc.
Healthsense is the fastest growing provider of technology-enabled care solutions for the senior care continuum. With a full range of remote monitoring, emergency response and wellness management solutions, Healthsense helps senior care providers and managed care organizations significantly reduce costs, increase independence and enhance caregiver and senior experiences. Built on a wireless platform, Healthsense products are scalable and enable flexible technology-enabled care designs that help in the delivery of the highest quality care across the entire care continuum. Visit www.healthsense.com for more information.

About Mansa Capital
Headquartered in Boston, Mass., with offices in New York City, Miami and Dallas, Mansa Capital is a private equity firm focused on the $2.5 trillion healthcare sector in the U.S. including Puerto Rico and the U.S. Virgin Islands. The firm uses its expertise in healthcare policy and economics to help management teams grow top line revenues and develop new products that build exceptional value. Mansa Capital’s principals bring to the firm extensive expertise in healthcare operations, marketing and finance including senior-level experience in healthcare compliance, regulation and reimbursement. The team has distinctive knowledge in the early identification of innovative business models that enable patients and providers to thrive in the post-healthcare reform environment. The firm also has special insights in the largely untapped Hispanic healthcare market. Visit www.mansancapital.com for more information. 

August 19, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Epion Health Receives $4.5M Series A Funding from Deerfield Management

ROSELAND, N.J.July 18, 2014 /PRNewswire/ — Epion Health announced the closing of a $4.5M Series A financing round with Deerfield Management Company, a New York City based investment firm. The funding will be used to scale Epion’s rapidly growing, iPad based, digital check-in and patient engagement platform used in healthcare facilities around the country.

This news comes on the heels of Epion’s recent announcement of a partnership and successful integration with athenahealth. Epion’s solution is now live and available to Athena’s network of 52,000 plus providers.

At the announcement, Epion’s CEO, Joe Blewitt said, “This additional capital comes into the company at an exciting time. We now have the necessary resources for the foreseeable future to capitalize on a very large market opportunity. In addition to growing our sales and operations teams, a portion of the funding will be used to continue to enhance our product for our rapidly growing network of providers. Our focus is on helping our providers increase revenues, decrease costs and improve patient satisfaction and patient outcomes. We’re excited to be partnering with Deerfield Management. In addition to deep pockets, Deerfield brings strong healthcare industry expertise and an extremely robust research arm to the table.”

Deerfield is committed to supporting innovative healthcare technology solutions and is excited about Epion’s ability to both improve practice level economics as well as enhance clinical care and patient experience,” remarked Leslie Henshaw, a Partner at Deerfield Management.

About Epion Health

Epion Health is a Healthbox Accelerator alumni company and offers a software as a service, patient engagement platform at the point of care, beginning with the patient check-in process. By replacing clipboards and paper forms with iPads, Epion improves efficiencies and engages patients to improve outcomes. The service fully integrates with Electronic Health Record and Practice Management systems.

About Deerfield Management Company 

Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information about Deerfield, please visit www.deerfield.com

July 22, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

CareCloud Raises $25.5 Million in Venture Debt from Hercules Technology Growth Capital

MIAMI–(BUSINESS WIRE)– CareCloud, the leading provider of cloud-based practice management, electronic health records (EHR), and medical billing software and services, today announced that it has received a $25.5 million debt financing commitment from Hercules Technology Growth Capital, Inc. (NYSE: HTGC), the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science, and energy & renewable technology industries, at all stages of development.

“We are thrilled to have the support and confidence of a leading technology investor like Hercules as we continue to execute on our aggressive business plan,” said R. Scott Lentz, Chief Financial Officer of CareCloud. “This commitment will enable us to accelerate the expansion of our technology solutions and further our strategic objective of providing the industry’s first modern cloud-based platform for healthcare.”

“We appreciate the opportunity to provide the financing required to advance CareCloud’s efforts to expand its market footprint and achieve its impressive growth objectives,” commented Tony Pandjiris, Managing Director at Hercules. “We are confident that CareCloud’s strong management team will be able to seize on the considerable market opportunity as medical groups look to modernize their IT infrastructure and deliver the best patient care possible.”

CareCloud reported record revenue increases during the first quarter of 2014, representing its 17th consecutive quarter of year-over-year triple-digit revenue growth. During the quarter, CareCloud also signed a record of over 170 new medical groups to its cloud-based platform. The Company’s cloud-based platform currently supports thousands of providers in 48 states and manages more than $3 billion in annualized accounts receivables on behalf of its clients. The Company’s award-winning platform also engages more than 8 million unique patients through CareCloud Community, which allows for greater patient engagement and care coordination and is the cornerstone of the company’s vision to be the industry’s Single Log In for Healthcare.

While many physician practices are increasingly concerned about the health of their practices, CareCloud offers products and services to help. The May 2014 Practice Profitability Index (PPI) surveyed over 5,000 U.S. physicians and found they are now more than twice as likely to foresee eroding, not increasing, profits in 2014. Those with a negative outlook increased from 36% to 39% during the past year, while optimists declined from 22% to 19%.The percentage of doctors spending more than one day a week on paperwork rose sharply between 2013 and 2014, from 58% to 70%. Nearly one-quarter (23%) spend more than 40% of their time on administration, up from 15% last year.

About Hercules Technology Growth Capital, Inc.

Hercules Technology Growth Capital, Inc. (NYSE: HTGC) is the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science, and energy & renewable technology industries, at all stages of development. Since inception (December 2003), Hercules has committed more than $4.2 billion to over 270 companies and is a lender of choice for entrepreneurs and venture capital firms seeking growth capital financing.

The Company’s common stock trades on the New York Stock Exchange under the ticker symbol “HTGC.”

In addition, Hercules has two outstanding bond issuances of 7.00 percent Senior Notes due 2019—the April 2019 Notes and September 2019 Notes—which trade on the NYSE under the symbols “HTGZ” and “HTGY,” respectively.

Companies interested in learning more about financing opportunities should contact info@htgc.com, or call 650.289.3060.

About CareCloud

CareCloud is the leading provider of cloud-based practice management, electronic health record (EHR), and medical billing software and services for medical groups. The company’s products are connecting providers to one another – and to their patients – through a fully integrated digital healthcare ecosystem that can be accessed on any browser or device.

CareCloud is helping thousands of physicians to increase collections, streamline operations and improve patient care in over 48 states, and currently manages over $3 billion in annualized accounts receivables on behalf of its revenue cycle management clients. To learn more about CareCloud, please visit www.carecloud.com.

June 26, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Kareo Secures $29.5 Million in Growth Capital

IRVINE, CA – January 21, 2014 – Kareo Inc., the leading provider of cloud-based medical office software and services for small medical practices, today announced it has secured $29.5 million in growth capital. This latest financing was led by Greenspring Associates and joined by OpenView Ventures and Silicon Valley Bank. This new capital will be used to invest in sales and marketing to accelerate growth, further enhance the company’s cloud-based software platform, and scale its revenue cycle management operations.

“We are thrilled to continue our successful partnership with investors Greenspring Associates and OpenView Ventures and welcome the new investment by Silicon Valley Bank,” said Dan Rodrigues, CEO and founder of Kareo. “This additional funding further validates our vision that Kareo’s cloud-based solutions can unleash the power of healthcare providers to deliver exceptional patient care while building thriving practices.”

“It’s been exciting to watch the impact that Kareo has had on small practices, including the recent launch of Kareo EHR and Billing Services,” said Jim Lim, partner at Greenspring Associates. “Given the company’s track record of rapid growth and market leadership, we jumped at the opportunity to deepen our partnership with Dan and his management team.”

Kareo’s latest funding follows a year of significant milestones and recognition within the healthcare technology industry, including:

  • The continued rapid growth of Kareo Practice Management, the company’s solution that serves more than 20,000 providers who processed over $6 billion in medical billing through Kareo’s platform last year.
  • The launch of Kareo EHR, the company’s free electronic health record solution that generated more than 5,000 sign-ups in less than ten months.
  • The introduction of Kareo’s technology-enabled revenue cycle management solution, Kareo Billing Services, which already manages billing for more than 1,000 providers across 46 specialties nationwide.
  • The successful acquisition and integration of Ecco Health, Kareo’s first acquisition, enabling the company to expand its services while deepening its revenue cycle management expertise across a wide range of specialties.
  • Extensive industry recognition, including the Deloitte Technology Fast 500, Inc. 500/5000, Forbes Top 100 Most Promising Companies, and Black Book #1 Integrated EHR, Practice Management and Billing Vendor.
  • Expansion of Kareo’s management team with the hiring of Tom Giannulli, MD as its Chief Medical Information Officer, Rob Pickell as its Chief Marketing Officer, Amyra Rand as its Vice President of Sales, David Mitzenmacher as its Vice President of Customer Success, and Nitin Somalwar as its Vice President of Engineering.

About Kareo

Kareo is the only cloud-based medical office software and services platform dedicated to small practices. At Kareo, we believe that, with the right tools and support, small practices can do big things. We offer an integrated suite of products and services designed to help physicians get paid faster, run their business smarter, and provide better care. Our Practice Management software, Billing Services, and free, full-featured award-winning EHR help more than 20,000 medical providers more efficiently manage the business and clinical sides of their practice. Headquartered in Irvine, California, Kareo’s mission is to help providers spend their time focused on patients, not paperwork. For more information, visit www.kareo.com.

About Greenspring Associates

Established in 2000 as a global venture capital firm, Greenspring Associates currently manages both a dedicated later stage direct investment platform as well as a globally diversified fund-of-funds platform with $2.5 billion under management. Since inception, the Firm has invested in over 60 portfolio companies alongside of its leading venture capital and growth equity managers both in the United States and Europe. Through the Firm’s value-added investment approach, it primarily invests across the information technology and communications stack as well as in the healthcare vertical. For further information, visit the Greenspring Associates website at www.greenspringassociates.com.

About OpenView Venture Partners

OpenView Venture Partners is an expansion-stage venture capital fund based in Boston that is focused on high-growth software, Internet and technology-enabled companies. Through its staff of seasoned operating executives, who collectively bring several decades of technology and management experience to the firm, OpenView is able to help portfolio companies quickly go to market and optimize their product, organization and operational functions. Founded in 2006, the firm invests globally and has approximately $440 million in total capital under management. For more information, visit

www.openviewpartners.com.

About Silicon Valley Bank

Silicon Valley Bank is the premier bank for technology, life science, cleantech, venture capital, private equity and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment and international banking services to its clients worldwide through 27 U.S. offices and six international operations. (Nasdaq: SIVB) www.svb.com.

Silicon Valley Bank is the California bank subsidiary and the commercial banking operation of SVB Financial Group. Banking services are provided by Silicon Valley Bank, a member of the FDIC and the Federal Reserve System. SVB Financial Group is also a member of the Federal Reserve System.

January 21, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Lumiata Raises $4 Million in Series A Financing from Khosla Ventures

The World’s First Medical Graph Aims to Revolutionize Health Care with Big Data Driven Medical Science and Predictive Analytics

San Mateo, California – January 8, 2013 – Lumiata, a provider of predictive analytics around medical science and patient data, announced today that it closed $4 million in Series A financing from Khosla Ventures. This funding will be used to refine and commercialize the health care industry’s first medical graph-­based predictive analytics engine, which is currently being piloted by major hospital networks and health insurance carriers to deliver better­informed patient care.

“There is little debate that health care delivery is lacking today – both in its quality and its affordability. Lumiata has created a new predictive engine to help turn the practice of medicine into a science,” said Vinod Khosla, founder of Khosla Ventures, a leading investor in transformational health care. “Lumiata’s medical graph helps providers ensure they’re giving the right care, at the right time, from the right person so they can deliver better value-­based health to more patients.”

Formerly known as MEDgle, Lumiata’s mission is to democratize medical science so that all kinds of medical staff – from advice nurses, to physician’s assistants, to doctors – can apply higher quality health care at a lower cost. The company collects massive amounts of medical science data, organizes it in rich, inter­-connected graphs similar to Facebook’s social graph, and produces key insights for patient care. Health providers can run anonymized medical records, genetic information or sensor data through Lumiata’s graph to receive hyper­-personalizedpredictions and recommendations for individual patients.

With instant access to Lumiata’s real­-time predictive and prescriptive analytics regarding symptoms, medications, risk factors and diagnoses, first­-line staff can elevate their day­-to­day care. The engine’s guidelines and protocols help nurses easily determine what questions to ask a patient and make knowledgeable decisions before and during a patient visit, such as which labs to order or which procedures to recommend. This approach also maximizes doctors’ productivity by marshaling the finest medical science at their fingertips, so they can determine diagnoses and treatment plans earlier and faster than ever before.

“We believe that data­-driven medical decisions can drive high quality, optimized care at a much lower cost,” said Ash Damle, founder and CEO of Lumiata. “At Lumiata, we’re providing the best of medical science on-­demand with a ‘GPS’­-like health navigation system. First we triangulate an individual’s health, and then we calculate their best routes to getting and staying healthy. These small, but life­-changing insights are the result of lots of sophisticated big data science.”

Behind the scenes, Lumiata’s technology ensures accurate health care predictions by combining the brilliance of the best physicians with the analytic power of big data. The company has crunched over 160 million data points from hundreds of relevant sources – including over seven million pages from textbooks and medical journals, and more than 100 gigabits of public data from the Centers for Disease Control, the National Institutes of Health, the World Health Organization and more – and spent over 20,000 physician hours to confirm the quality of its resulting insights. Its algorithms turn raw data about tens of thousands of symptoms, diagnoses, procedures and medications across ages, genders and lifestyles into curated, usable bigknowledge to dramatically improve the delivery of health care.

Lumiata’s real-­time predictive analytics are available via Application Programming Interfaces (APIs). These APIs can be used to pull both aggregate and specific patient insights into the systems, devices and daily workflows that hospitals and insurers already use during patient interactions. In the future, Lumiata will also leverage its medical graph to give individuals the data they need to optimize their own health and wellness every day.

Lumiata’s management team and advisory board include board­-certified physicians, data scientists, and evidence-­based medical researchers. Its CEO, Ash Damle, founded the company to synthesize fifteen years of research on applying practical artificial intelligence. His background includes developing web-­scale artificial intelligence solutions at Massachusetts Institute of Technology, the U.S. Navy, California’s Department of Corrections and Rehabilitation and J.Crew. In addition, Euan Thomson, investment partner at Khosla Ventures, is joining the company’s board of directors and brings over fifteen years of experience as a scientist, physicist and researcher in the United Kingdom’s health care system.
About Lumiata

Founded in 2013, Lumiata (formerly MEDgle) applies big data­-driven medical science to patient data in order to optimize every health care interaction. The company delivers real­-time predictive analytics that help hospital networks and insurance carriers provide higher quality care to more patients in less time. To produce accurate insights and predictions related to symptoms, diagnoses, procedures and medications, Lumiata developed the world’s first medical graph, which organizes and analyzes hundreds of millions of valuable data points. Lumiata is a venture-­backed company based in Silicon Valley and composed of clinicians, data scientists, and experts in care delivery. More information is available at www.lumiata.com.
About Khosla Ventures

Khosla Ventures offers venture assistance, strategic advice and capital to entrepreneurs. The firm helps entrepreneurs extend the potential of their ideas in breakthrough technologies in clean energy, mobile, IT, cloud, big data, storage, health, food, agriculture and semiconductors. VinodKhosla founded the firm in 2004 and was formerly a General Partner at Kleiner Perkins and founder of Sun Microsystems. Khosla Ventures is based in Menlo Park, California. More information is available at http://www.khoslaventures.com.

January 8, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

BetterDoctor Raises $2.6M Seed Funding

BetterDoctor is doctor-finding service based on hundreds of public and private data sources. We have 1 million doctors in our database and have helped 4 million people to find a quality doctor.

We have raised $2.6M in seed funding to grow into a matchmaking service for patients and doctors.

The founder’s story

In 2011, my family experienced a series of life-changing medical emergencies which required a team of over 15 doctors and specialists. Unfortunately, finding those specialists was a huge time sink.

I soon understood the pain of the 70+ million Americans looking for new doctors every year – and soon even 30 million more people because of Obamacare. There simply wasn’t a good way to find quality doctors.

Drawing on a background in gaming and technology, my co-founder Tapio Tolvanen and I both left our positions at Nokia to found BetterDoctor. I used to lead Nokia’s App Studios, Tapio was Chief Architect and Head of Technology. We studied the problem closely, built a team and a system to solve it, and launched BetterDoctor a year ago.

Since debuting at TC DISRUPT in 2012, over 4 million people have used BetterDoctor to search for high-quality doctors in their area and insurance network. Today, almost 1 million people rely on BetterDoctor each month to find new doctors. We’ve designed a beautiful mobile web experience to make it available on all devices.

About BetterDoctor, the product
Designed to complement traditional user-generated ratings and reviews, BetterDoctor draws on an array of public and privately available quality indicators to rank every doctor in the United States.

A few of the factors we examine–which most people either don’t have access to or typically look for–include:

  • Experience
  • Education
  • Medical licensing
  • Board certification
  • Judicial sanctions
  • Professional and referral network

BetterDoctor’s Funding
We are very excited to have a great mix health and consumer web investors join the mission! The $3.6M Seed round was led by SoftTechVC and Burrill & Co. Jeff Clavier from SoftTechVC, Dirk Lammerts from Burrill & Co and Kristian Segerstrale from Initial Capital joined the board.

Notable investors:

SoftTechVC (Silicon Valley, USA)
The leading early stage investors with web and mobile focus. 125 Seed-round and A-round investments.
http://softtechvc.com/

Burrill & Company (Silicon Valley, USA)
The leading LifeScience and digital health fund with over $2B in management.
http://www.burrillandco.com/

500 Startups (Silicon Valley, USA)
The world’s most active seed fund and influential incubator lead by Dave McClure. Have done 500 investments.
http://500.co/

WTI (Silicon Valley, USA)
Western Technology Investment: the first investors in Facebook and Google. Over $2B in investments.
http://www.westerntech.com/

Lifeline Ventures (Helsinki, Finland)
One of the leading European early stage investors behind Supercell and other successful Finnish companies.
http://www.lifelineventures.com/

Initial Capital (Silicon Valley, USA)
Social media, gaming, consumer web and mobile focused Seed Fund. Lead by Finnish serial entrepreneur Kristian Segerstrale (Playfish, EA).
http://www.initialcapital.com/

Commerce Ventures (Silicon Valley, USA)
Venture fund focused on Online Marketplaces
http://commercevc.com/

MESA+ (New York, USA)
Media and commerce focused seed fund in New York
http://www.mesaglobal.com/

Kima Ventures (Paris, France)
Active angel/seed stage investor with web and mobile focus
http://www.kimaventures.com/

October 22, 2013 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Greenway Medical Technologies and Vitera Healthcare Solutions to Combine

Vista Equity Partners, owner of Vitera, to acquire all outstanding Greenway common stock for

$20.35 per share in a transaction valued at approximately $644 million

Carrollton, GA, and Tampa, FL, Sept. 23, 2013 – Greenway Medical Technologies, Inc. (NYSE: GWAY) today announced a definitive agreement which will result in the combination of the businesses of Greenway and Vitera Healthcare Solutions, LLC. The transaction will create a leader in healthcare information technology and services, offering a comprehensive set of solutions to improve clinical and financial outcomes in healthcare enterprises, ambulatory practices, public health, retail and other clinics nationwide. Following the closing of the transaction, the Vitera and Greenway businesses will serve nearly 13,000 medical organizations and 100,000 providers.

Under the terms of the agreement, Vista Equity Partners, which owns Vitera Healthcare Solutions, will pay Greenway stockholders $20.35 in cash for each share of Greenway common stock they hold. The price represents a 62% premium to Greenway’s 90-day volume weighted average stock price and a 20% premium to Greenway’s closing share price the day before the merger agreement was signed. The all-cash transaction is valued at approximately $644 million. The Greenway Board of Directors has unanimously approved the definitive merger agreement. Upon closing, Greenway will operate as a privately held company.

“We are pleased to approve this agreement and look forward to completing this transaction,” said W. Thomas ‘Tommy’ Green, founder of Greenway Medical Technologies and Chairman since the company’s inception in 1998. “It provides substantial cash value for our stockholders, and reflects our deep commitment to drive innovation that helps healthcare professionals succeed and thrive in today’s evolving healthcare landscape.”

It is anticipated that the Vitera and Greenway businesses will continue as Greenway Medical Technologies with the products and services of both Greenway and Vitera marketed under the Greenway brand. After closing, the two businesses will continue together to deliver best-in-class solutions and services, and enhancement of existing product platforms to ensure customers have the tools they need to address payment reform models and meet regulatory requirements such as Meaningful Use Stage 2 and the transition to ICD-10.

Greenway will continue to have headquarters and principal operations in Carrollton, GA, Tampa, FL and Birmingham, AL.

“This transaction presents an opportunity to offer even greater value to our customers,” said Matthew J. Hawkins, President and CEO of Vitera. “Combining our business with Greenway Medical Technologies demonstrates our intense focus on growth and our commitment to provide current and prospective customers with proven, integrated and easy-to-use solutions they need to grow profitably, increase practice efficiencies and improve patient outcomes in this ever-changing healthcare environment.”

“We are excited that the transaction will accelerate the execution of our clearly defined strategy of leading the electronification of healthcare, engaging consumers in the management of their own health and continuing to partner with providers to develop the tools to improve population health,” said Tee Green, President and CEO of Greenway.

Greenway’s platforms are consistently recognized for ease of use at the point of care, which has led to high adoption rates among care providers, as well as having an industry-leading interoperability strategy that promotes the flow of data across healthcare systems. Greenway’s clinically driven revenue cycle management platform enables providers to thrive while participating in evolving and increasingly more complex reimbursement programs that are based on clinical outcomes.

Vitera’s first-place EHR ranking from independent researcher Black Book Market Research, LLC and recent Customer Value Enhancement Award from Frost & Sullivan underscore the value of Vitera’s industry-leading solutions and services. Vitera’s portfolio of highly interoperable EHR and practice management solutions is ICD-10-enabled, certified for Meaningful Use Stage 2, and approved for pre-validation as a Patient-Centered Medical Home.

Under the terms of the agreement, an affiliate of Vista Equity Partners will commence a tender offer for all of the outstanding shares of Greenway’s common stock. Closing of the transaction is conditioned upon, among other things, satisfaction of a minimum tender condition, clearance under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, and other customary closing conditions. The closing of the transaction is not contingent on financing. In the event that the minimum tender condition is not met, and in certain other circumstances, the parties have agreed to complete the transaction through a one-step merger after receipt of stockholder approval. Greenway expects the transaction to close in the fourth calendar quarter of 2013.

Certain of Greenway’s stockholders (Investor Group L.P., Investor Growth Capital Limited and Pamlico Capital II, L.P.), each of Greenway’s directors (W. Thomas Green, Jr., Wyche T. Green, III, Robert Hensley, Neal Morrison, Thomas T. Richards, Walter Turek and Noah Walley), and certain executive officers of Greenway, including Gregory H. Schulenburg (Executive Vice President and Chief Operating Officer), James A. Cochran (Chief Financial Officer) and William G. Esslinger, Jr. (Vice President, General Counsel and Secretary), have each agreed to tender their shares into the offer, and vote their shares in favor of the definitive merger agreement and the merger, subject to certain terms and conditions. These stockholders collectively own approximately 50.9% of Greenway’s outstanding shares. These agreements will terminate upon termination of the definitive merger agreement in accordance with its terms in order for the Company to accept a superior offer and upon certain other circumstances.

The affiliate of Vista has obtained equity and debt financing commitments for the transactions contemplated by the merger agreement, the aggregate proceeds of which will be sufficient for Vista’s affiliate to pay the aggregate merger consideration and all related fees and expenses. Vista has committed to capitalize its affiliate, at or immediately prior to the effective time of the merger, with an aggregate equity contribution in an amount up to $650 million, which will be sufficient for the Affiliate to consummate the transactions contemplated by the merger agreement even if Vista’s debt financing is not available, subject to the terms and conditions set forth in an equity funding commitment letter, dated as of September 23, 2013.

J.P. Morgan is serving as financial advisor to Greenway, and Paul Hastings LLP is serving as Greenway’s legal advisor. Jefferies LLC and BMO Capital Markets are serving as financial advisors to the buyer, and Kirkland & Ellis LLP is serving as the buyer’s legal advisor. Jefferies Finance LLC and BMO Capital Markets have agreed to provide debt financing in connection with the transaction.

For further information regarding all terms and conditions contained in the definitive merger agreement, please see Greenway’s Current Report on Form 8-K, which will be filed in connection with this transaction.

# # #

About Greenway and PrimeSUITE

Greenway Medical Technologies (NYSE: GWAY) delivers smarter information solutions that improve the financial performance of healthcare providers and enable them to deliver smarter care. Greenway PrimeSUITE® — the company’s certified, single-database electronic health record, practice management and interoperability solution platform — is complemented by an expanding array of integrated business and data services, including clinically driven revenue cycle management (RCM). Thousands of care providers across primary care and more than 30 specialties and sub-specialties use cloud-based or on-premise Greenway® solutions to improve outcomes in healthcare enterprises, physician practices, retail and other ambulatory clinics, and alternate care venues nationwide. For details, see greenwaymedical.comTwitterFacebook or YouTube.

About Vitera Healthcare Solutions

Vitera Healthcare Solutions provides end-to-end clinical and financial technology solutions so physicians and medical professionals can work with patients instead of paperwork. Serving more than 415,000 healthcare professionals including 85,000 physicians, Vitera Healthcare Solutions provides electronic health records and practice management systems, processes 33 million transactions and 2 million e-prescriptions monthly, and serves several specialties including primary care, OB/GYN, pediatrics, cardiology and orthopedics in all sized practices and Community Health Centers. Physician-focused and patient-centric, Vitera Healthcare Solutions is based in Tampa, FL. For more information, visit www.viterahealthcare.com  or call (877) 932-6301. Follow Vitera Healthcare Solutions on Facebook a thttp://www.facebook.com/viterahealthcare, and Twitter at https://twitter.com/ViteraHealth.

About Vista Equity Partners
Vista Equity Partners, a U.S.-based private equity firm with offices in San Francisco, Chicago and Austin, currently invests over $7.1 billion in capital committed to dynamic, successful technology-based organizations led by world-class management teams with long-term perspective. Vista is a value-added investor, contributing professional expertise and multi-level support towards companies realizing their full potential. Vista’s investment approach is anchored by a sizable long-term capital base, experience in structuring technology-oriented transactions, and proven management techniques that yield flexibility and opportunity in private equity investing. For further information please visit www.vistaequitypartners.com.

Important Additional Information

This press release is neither an offer to purchase nor a solicitation of an offer to sell shares of Greenway. The tender offer for securities of Greenway described in this press release has not yet been commenced. The offer to buy securities of Greenway described in this press release will be made only pursuant to the offer to purchase and related materials that Vista Equity Partners will file on Schedule TO with the SEC. At the same time or soon thereafter, Greenway will file its recommendation of the tender offer on Schedule 14D-9 with the SEC. In connection with the proposed transaction, Greenway will also file a preliminary proxy statement with the SEC. Additionally, Greenway and Vista Equity Partners will file other relevant materials in connection with the proposed acquisition of Greenway by affiliates of Vista Equity Partners pursuant to the terms of the merger agreement. INVESTORS AND STOCKHOLDERS OF GREENWAY ARE ADVISED TO READ THE SCHEDULE TO, THE SCHEDULE 14D-9, AND THE PRELIMINARY PROXY STATEMENT, AS EACH MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME, AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BEFORE THEY MAKE ANY DECISION WITH RESPECT TO THE TENDER OFFER OR MERGER, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND THE PARTIES THERETO.

Investors and stockholders may obtain free copies of the Schedule TO, Schedule 14D-9 and preliminary proxy statement, as each may be amended or supplemented from time to time, and other documents filed by the parties (when available), at the SEC’s Web site at www.sec.gov or at Greenway’s Web site at www.greenwaymedical.com. The Schedule TO, Schedule 14D-9 and preliminary proxy statement, as each may be amended or supplemented from time to time, and such other documents may also be obtained, when available, for free from Greenway by contacting Greenway’s Investor Relations Department at 1.866.242.3805 or by email through Greenway’s investor relations page athttp://ir.greenwaymedical.com/.

Greenway and its respective directors, executive officers and other members of its management and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of Greenway’s stockholders in connection with the proposed Merger. Investors and security holders may obtain more detailed information regarding the names, affiliations and interests of certain of Greenway’s executive officers and directors in the solicitation by reading Greenway’s proxy statement for its 2012 annual meeting of stockholders, the Annual Report on Form 10-K for the fiscal year ended June 30, 2013, and the proxy statement and other relevant materials which may be filed with the SEC in connection with the Merger when and if they become available. Information concerning the interests of Greenway’s participants in the solicitation, which may, in some cases, be different than those of the Company’s stockholders generally, will be set forth in the proxy statement relating to the Merger when it becomes available. Additional information regarding Greenway’s directors and executive officers is also included in Greenway’s proxy statement for its 2013 annual meeting of stockholders and is included in Part III of the Annual Report on Form 10-K for the fiscal year ended June 30, 2013.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements with respect to the tender offer and related transactions, including the benefits expected from the transaction and the expected timing of the completion of the transaction.  When used in this press release, the words “can,” “will,” “intends,” “expects,” “is expected,” similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements.  Such statements are based on a number of assumptions that could ultimately prove inaccurate, and are subject to a number of risk factors, including uncertainties regarding the timing of the closing of the transaction, uncertainties as to how many stockholders of Greenway may tender their stock in the tender offer, the possibility that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the transaction, and general economic and business conditions.  None of Vista Equity Partners, Vitera or Greenway assumes any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Factors that could cause actual results of the tender offer to differ materially include the following: the risk of failing to obtain any regulatory approvals or satisfy conditions to the transaction, the risk that Vista Equity Partners is unable to obtain adequate financing, the risk that the transaction will not close or that closing will be delayed, the risk that Greenway’s businesses will suffer due to uncertainty related to the transaction, the competitive environment in our industry and competitive responses to the transaction as well as risk factors set forth above.  Further information on factors that could affect Greenway’s financial results is provided in documents filed by Greenway with the U.S. Securities and Exchange Commission, including Greenway’s recent filings on Form 10-Q and Form 10-K.

Greenway, the Greenway logo and PrimeSUITE are registered trademarks and the phrase “clinically driven revenue cycle management” is a trademark of Greenway Medical Technologies, Inc. Other product or company names are the property of their respective owners.

# # #

Greenway Media Contact:

Bob Kneeley

(678) 390-7262

BobKneeley@greenwaymedical.com

Vitera Healthcare Solutions Media Contact:

Elizabeth Glaser

Dodge Communications

(770) 576-2551/(770) 317-8831

eglaser@dodgecommunications.com

September 23, 2013 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

CareCloud Announces an Additional $9 Million from Adams Street Partners as Part of Series B Funding Round

MIAMI & BOSTON–(BUSINESS WIRE)– CareCloud, the fastest-growing provider of cloud-based practice management, electronic health records (EHR), and medical billing software and services, today announced it has secured an additional $9 million from Adams Street Partners as part of the Company’s Series B financing round. On June 18, 2013, CareCloud announced it had secured $20 million in Series B funding, led by Tenaya Capital and included existing investors Intel Capital and Norwest Venture Partners. This additional funding was the result of continued interest from investors to participate in CareCloud’s latest round, which is now closed at $29 million, and brings CareCloud’s total funding to $55 million. Adams Street Partners is one of the world’s largest managers of private equity for institutional investors and currently manages over $25 billion of committed capital for institutional investors.

“We are very excited to have Adams Street Partners invest in CareCloud as part of our Series B funding raise, which received tremendous interest from the investment community. This oversubscription of this round only further validates our business model and opportunity,” said Albert Santalo. “We will deploy this capital in an aggressive fashion in order to support our continuing efforts to disrupt the legacy players in healthcare IT. We will continue ramping our investments in R&D to further accelerate the realization of our mission to re-platform healthcare using modern, cloud-based technology.”

In July, CareCloud reported record revenue increases during the second quarter of 2013, representing its 14th consecutive quarter of growth. During the quarter, CareCloud also signed a record 150 new medical groups to its cloud-based platform with more than half selecting the Company’s integrated EHR and practice management solution. The company’s cloud-based platform currently supports 3,500 providers in 46 states and manages more than $2 billion in annualized accounts receivables on behalf of its clients. The Company’s award-winning platform also engages more than 5 million unique patients throughCareCloud Community, which allows for greater patient engagement and care coordination and is the cornerstone of the company’s vision to be the industry’s Single Log In for Healthcare.

We were excited to have the opportunity to invest in CareCloud given the significant interest the company generated during this funding round. We feel CareCloud represents a major disruptive force in healthcare. Their innovative technology is allowing them to address the needs of small independent physicians to large enterprise care delivery organizations as they look to automate their operations and adhere to new industry dynamics,” said Jeffrey Diehl, Partner at Adams Street Partners.

About Adams Street Partners

Adams Street Partners is an independent, employee-owned private equity firm that manages over $25 billion of committed capital for institutional investors. The firm has offices in Chicago, Menlo Park, London, Beijing and Singapore. Adams Street was a pioneer in the development of the private equity secondary market, closing its first secondary transaction in 1986. The dedicated secondary investment team of professionals in London, Singapore and Chicago executes a selective, global investment strategy following a theme-based approach that leads to targeting specific funds. Adams Street Partners is widely recognized as the oldest fund of funds manager in the industry, establishing its first such fund for institutional investors in 1979. For more information, please visit www.adamsstreetpartners.com

About CareCloud

CareCloud is a leading provider of cloud-based practice management, electronic health record (EHR), and medical billing software and services for medical groups. The company’s products are connecting providers to one another – and to their patients – through a fully integrated digital healthcare ecosystem that can be accessed on any browser or device.

CareCloud is helping thousands of physicians to increase collections, streamline operations and improve patient care in over 46 states and currently manages over $2 billion in annualized accounts receivables on behalf of its revenue cycle management clients. To learn more about CareCloud, please visitwww.carecloud.com.

August 15, 2013 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

CareCloud EHR Raises $20 Million

MIAMI–(BUSINESS WIRE)– CareCloud, the fastest-growing provider of cloud-based practice management, electronic health records (EHR), and medical billing software and services, today announced it has secured $20 million in Series B financing. The funds will fuel the Company’s continued aggressive growth across all business functions, with a focus on product development while also bolstering sales and marketing capabilities. The funding round was led by Tenaya Capital and included existing investors Intel Capital and Norwest Venture Partners. This round brings CareCloud’s total funding to $44 million. Stewart Gollmer, Tenaya Capital’s Managing Partner, will join CareCloud’s Board of Directors.

“Most of the U.S. healthcare system is shackled with decades-old technology that will hinder us from improving patient care or delivering on cost containment efforts in a rapidly-changing environment of reform,” said Albert Santalo, CareCloud’s Chairman and CEO. “This investment validates CareCloud’s mission to aim at the heart of the challenge by leveraging the power of the cloud to foster innovation and ultimately replatform the industry. I am very pleased to welcome Tenaya Capital to our strong base of investors.”

CareCloud’s cloud-based platform now powers close to 3,000 providers in 45 states as medical groups look to improve their operational and clinical outcomes amidst a rapidly changing healthcare reimbursement environment. CareCloud manages more than $2 billion in annualized accounts receivables on behalf of its clients leveraging its cloud-based revenue cycle management service. The Company’s award-winning platform currently supports more than 5 million unique patients that will be increasingly engaged through the Company’s CareCloud Communityoffering that allows for greater care coordination and is the cornerstone of CareCloud’s vision to be the industry’s Single Log In for Healthcare.

“Technology will play an increasingly significant role in the transformation of how healthcare is delivered and paid for in this country. It’s clear that the current solutions are either decades old client-server technology or outdated web-based architecture,” said Gollmer. “CareCloud and its modern platform represent a tremendous opportunity to bridge the technology gap that plagues the healthcare ecosystem. We are excited to invest in CareCloud and feel that the company represents a powerful combination of industry-leading vision and exemplary execution, driven by a remarkable team.”

Physicians See Better Billing, Technology As Keys To Higher Performance

The May 2013 Practice Profitability Index (PPI), which serves as an annual barometer for the operational wellbeing of U.S. medical groups in the year ahead, surveyed more than 5,000 physicians across the nation and uncovered a downward trend in profitability for the year ahead, which is driving a growing “rip and replace” market for technology. It found that, of the 41% of practices with specific plans aimed at operational improvements in the coming year, the main interventions are: implementing a new EHR (41%), replacing their existing EHR (25%), outsourcing billing/collections (18%) and replacing their practice management system (16%). Furthermore, the majority of physicians (52%) are uncertain if their practice management systems will accommodate regulatory changes in the year ahead. The complete 2013 PPI findings can be accessed at www.poweryourpractice.com/PPI.

Tenaya Capital is a leading venture capital firm with a history of investing in disruptive and category-leading companies including HubSpot, Zuora, RightScale, and Zappos. Intel Capital and Norwest Venture Partners led CareCloud’s $20.1 million Series A funding in September of 2011.

About Tenaya Capital

Tenaya Capital is a leading venture capital firm with offices in Woodside, California, and Boston, Massachusetts. Founded in 1995 as Lehman Brothers Venture Partners, they became an independent company in 2009. Over the years they’ve raised five funds representing over $1 billion of committed capital, investing it in a wide range of high-growth technology companies including software, consumer Internet, communications, semiconductors, electronics, and cleantech. For more information visit www.tenayacapital.com

About CareCloud

CareCloud is a leading provider of cloud-based practice management, electronic health record (EHR) and medical billing software and services for medical groups. The company’s products are connecting providers to one another – and to their patients – through a fully integrated digital healthcare ecosystem that can be accessed on any browser or device.

CareCloud is helping thousands of physicians to increase collections, streamline operations and improve patient care in over 45 states and currently manages over $2 billion in annualized accounts receivables on behalf of its revenue cycle management clients. To learn more about CareCloud, please visit www.carecloud.com.

June 18, 2013 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

ZyDoc Expands NIH SBIR NLP Grant for EHR Usability Research Study to Other Facilities

Islandia, NY February 8, 2013 – ZyDoc, an Islandia, NY-based medical informatics company, has been awarded Phase I SBIR grant funding by the National Library of Medicine of the National Institutes of Health for a study involving ZyDoc’s NLP-powered MediSapien™ knowledge management platform.  James M. Maisel, M.D., Chairman of ZyDoc is the Principal Investigator (P.I.) for the project, entitled “Applying NLP to Free Text as an EHR Data Capture Method to Improve EHR Usability.” The study compares the documentation quality, efficiency, and user satisfaction resulting from a method of EHR data capture involving MediSapien NLP (natural language processing) with results from standard methods. ZyDoc was among only 16% of NLM grant applicants to be awarded funding in 2011. The $150,000 project is funded entirely from the grant and is a potential precursor to Phase II funding.

ZyDoc has received IRB approval from a prominent New York-area teaching hospital for the research study, and additional test sites are now being sought. Researchers at Columbia University will be participating in the study, which also measures the accuracy of ICD-10 coding generated by MediSapien NLP. Facilities interested in participating in the study, including public or private hospitals and physician groups, are invited to contact James Maisel at grant@medisapien.com.

MediSapien was launched at the HIMSS Annual Conference in February 2012 expanding the ZyDoc family of documentation and knowledge management solutions featuring NLP-powered generation of structured codes from unstructured text.  Those codes are formulated in industry standard HL7 CDA Level III R2 messages suitable for insertion in any ONC-certified EHR. MediSapien solutions are primarily marketed through its channel partner network, which includes EHRs, Billing and RCM providers, Analytics companies, and MTSOs. For EHR Channel Partners, MediSapien offers a value-added service to provide objective third-party usability evaluations. For clinician end-users, MediSapien can be utilized in conjunction with existing or planned EHR installations, and can facilitate compliance with Meaningful Use mandates.

“This is an exciting time for ZyDoc and MediSapien” explains Maisel. “While we prove out our solutions in the marketplace in 2013, the grant allows ZyDoc to scientifically measure the usability, efficiency and accuracy of MediSapien.  In the study, doctors will complete typical medical encounters with dictation vs. EHR data entry with keyboard and mouse.  The text will be inserted into the EHR along with the structured coded data extracted by MediSapien. The resultant EHR documentation will be analyzed by document experts and graded for accuracy and other parameters. The SBIR-funded study is a potential precursor to Phase II-funding.”

A research collaborator on the study, David Kaufman, PhD, formerly a research scientist at Columbia University and now at the University of Arizona, offers this perspective, “Although EHRs are promising tools for improving healthcare, it is widely known that the user experience is frequently suboptimal resulting in dissatisfaction and low rates of adoption. This is partly due to the fact that clinicians spend many hours interacting with unwieldy systems documenting patient records. MediSapien is a promising instrument that may serve to reduce the cognitive burden on clinicians and enable EHRs to be instruments of clinical communication and tools that can greatly enhance patient care.”

About ZyDoc and MediSapien

Based in Islandia, New York, ZyDoc is a national leading-edge medical knowledge management company founded in 1993 to develop medical informatics solutions. Under the leadership of James M. Maisel, M.D., Chairman, the company has developed award-winning documentation and knowledge management solutions.  The e-transcription infrastructure and speech recognition solutions are now complemented by the disruptive enabling MediSapien NLP technology. The ZyDoc suite of tools can be assembled into seamless flexible solutions for documentation and knowledge management needs. Each award-winning, easy to use module offers the best-in-class performance and is designed to be seamless integrated in a scalable, interoperable, HIPAA secure customizable solution.   Cloud based ZyDoc solutions are always accessible and robust and offer enhanced capabilities for medical knowledge workers.

Research reported in this publication was supported by the National Library of Medicine of the National Institutes of Health under Award Number R43LM011165. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

February 15, 2013 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.